Contents of this document
| Item | Details |
|---|---|
| Document type | Earnings presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥1,524 hundred million (YoY +9.4%) |
| Operating profit | ¥140 hundred million (YoY +7.7%) |
| Ordinary income | ¥146 hundred million (YoY +18.1%) |
| Net income | ¥94 hundred million (YoY -2.7%) |
| Results for the three months of the current quarter | Net Sales ¥1,524 hundred million / Operating profit ¥140 hundred million / Ordinary income ¥146 hundred million / Profit attributable to owners of parent for the quarter ¥94 hundred million |
| Full-year earnings forecast | Net Sales ¥5,950 hundred million / Operating profit ¥425 hundred million / Ordinary income ¥430 hundred million / Profit attributable to owners of the parent ¥270 hundred million |
| Self-assessment against the plan | Q1 results exceeded the initial plan. Progress is nevertheless expected to be in line with the company plan. |
| Segment results | High Performance Polymers Net Sales ¥64.2 billion (up 23.9% year on year) / Operating profit ¥8.1 billion (up 20.9% year on year) / Materials Net Sales ¥45.7 billion (down 6.2% year on year) / Operating profit ¥4.2 billion (up 2.1% year on year) / Safety Net Sales ¥26.5 billion (up 8.2% year on year) / Operating profit ¥0.3 billion (down 80.8% year on year) / Smart Net Sales ¥10.6 billion (up 12.4% year on year) / Operating profit ¥0.7 billion (up 215.5% year on year) / Life Science Net Sales ¥4.9 billion (up 15.8% year on year) / Operating profit ¥0.5 billion (up 138.8% year on year) / Other Businesses Net Sales ¥0.4 billion (down 20.0% year on year) / Operating profit ¥0.2 billion (up 38.1% year on year) |
| Breakdown of Factors Affecting the Change | Year-on-year change in consolidated operating profit Volume impact +¥1.5 billion, price impact -¥2.2 billion, other factors +¥1.6 billion, foreign exchange impact +¥2.5 billion / Year-on-year change in consolidated revenue Volume variance +¥1.6 billion, unit price variance +¥11.6 billion, including foreign exchange impact of +¥10.2 billion |
| Key KPIs | EBITDA ¥24.8 billion (up 8.4% year on year) / Exchange rate ¥159/USD / Asian methanol spot price 522 USD/ton / Dubai crude oil 97 USD/bbl / Domestic naphtha ¥117,000/kl |
| Unit price and quantity metrics | Volume and price impacts for each segment disclosed |
| Assumptions Underlying the Business Outlook | Exchange rate ¥150/USD / Asian methanol spot price 330 USD/ton / Dubai crude oil 70 USD/bbl / Domestic naphtha ¥65,000/kl |
| Risk amount incorporated into the outlook | Anticipated loss of approximately ¥0.8 billion (shutdown of the CO and acetic acid plants) |
| Annual Dividend | ¥70/share (interim ¥35, planned year-end ¥35) |
| Capital expenditures | ¥635 billions (forecast for the fiscal year ending March 2027) |
| New initiatives | Segment changes from the fiscal year ending March 2027, shutdown, inspection and remedial measures for the CO plant and other facilities, cancellation of 10.8 million treasury shares, and progressive dividends based on a total payout ratio of 60% or more and DOE of 5% or more |
Items this document does not state (13)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased due to higher sales volumes of POM, LCP and other products in the High Performance Polymers business, the passing through of higher raw material and fuel costs, and foreign exchange effects. Operating profit benefited from higher sales, price pass-through and foreign exchange effects, while higher raw material and fuel costs and lower sales volumes of inflators to China in the Safety business were limiting factors. Net income declined due to the absence of subsidy income recorded in the year-earlier period.